
The disease anthrax is caused by lethal factor, an enzyme component of the toxin produced by the spore-forming bacterium Bacillus anthracis. Here we describe substrate molecules for this factor that offer a means for high-throughput screening of potential inhibitors for use in anthrax treatment. Our assay should help to answer the urgent call for new and specific therapies to combat this pathogen after its recent emergence as a terrorist bioweapon.
Antigens, Bacterial, Macrophages, Bacterial Toxins, Drug Evaluation, Preclinical, Cell Line, Substrate Specificity, Anthrax, Bacillus anthracis, Humans, Mitogen-Activated Protein Kinases
Antigens, Bacterial, Macrophages, Bacterial Toxins, Drug Evaluation, Preclinical, Cell Line, Substrate Specificity, Anthrax, Bacillus anthracis, Humans, Mitogen-Activated Protein Kinases
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 110 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Top 10% | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Top 10% | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Top 1% |
